Inhibition and induction of drug metabolism by psoralens: Alterations in duration of sleep induced by hexobarbital and in clearance of caffeine and hexobarbital in mice

References

• Albrightson C. R., Fertel R. H., Brown B. V., Stevens R. Psoralens increase the concentration of cyclic AMP in human cells in vitro. Journal of Investigative Dermatology 1985; 85: 264–268
   PubMedGoogle Scholar
• Aldridge A., Parsons W. D., Neims A. H. Simulation of caffeine metabolism in the rat by 3-methylcholanthrene. Life Science 1977; 21: 967–974
   PubMed Web of Science ®Google Scholar
• Alter H. J., Creagan R. P., Morel P. A., Weisehahn G. P., Dorman B. P., Corash L., Smith G. C., Popper H., Eichberg J. W. Photochemical decontamination of blood components containing hepatitis B and non-A, non-B virus. Lancet 1988; 2: 1446–1450
   PubMedGoogle Scholar
• Anderson T. F., Voorhees J. J. Psoralen photochemotherapy of cutaneous disorders. Annual Review of Pharmacology and Toxicology 1980; 20: 235–257
   PubMed Web of Science ®Google Scholar
• Apseloff G., Shepard D. R., Chambers M. A., Nawoot S., Mays D. C., Gerber N. Inhibition and induction of theophylline metabolism by 8-methoxypsoralen: in vivo study in rats and humans. Drug Metabolism and Disposition 1990; 18: 298–303
   PubMed Web of Science ®Google Scholar
• Arnaud M. J. Comparative metabolic disposition of [1-Me14C]caffeine in rats, mice, and Chinese hamsters. Drugs Metabolism and Disposition 1985; 13: 471–478
   PubMed Web of Science ®Google Scholar
• Beach C. A., Mays D. C., Sterman B. M., Gerber N. Metabolism, distribution, seminal excretion and pharmacokinetics of caffeine in the rabbit. Journal of Pharmacology and Experimental Therapeutics 1985; 233: 18–23
   PubMedGoogle Scholar
• Bisaccia E., Berger C., Klainer A. S. Extracorporeal photopheresis in the treatment of AIDS-related complex: a pilot study. Annals of Internal Medicine 1990; 113: 270–275
   PubMedGoogle Scholar
• Callahan M. M., Robertson R. S., Arnaud M. J., Branfman A. R., McComish M. F., Yesair D. W. Human metabolism of [1-methyl-14C] and [2-14C] caffeine after oral administration. Drug Metabolism and Disposition 1982; 10: 417–423
   PubMed Web of Science ®Google Scholar
• Cox G. W., Orosz C. G., Fertel R. H. 8-Methoxypsoralen inhibits lymphocyte proliferation in vitro in the absence of ultraviolet radiation. International Journal of Immuno-pharmacology 1987; 4: 475–481
   Google Scholar
• Edelson R., Berger C., Gasparro F., Jegasothy B., Heald P., Wintroub B., Vonderheid E., Knobler R., Wolff K., Plewig G., McKiernan G., Christiansen I., Oster M., Honigsmann H., Wilford H., Kokoschka E., Rehle T., Perez M., Stingl G., Laroche L. Treatment of cutaneous T-cell lymphoma by extracorporeal photochemotherapy. New England Journal of Medicine 1987; 316: 297–303
   PubMed Web of Science ®Google Scholar
• Fouin-Fortunet H., Tinel M., Descatoire V., Letteron P., Larrey D., Geneve J., Pessayre D. Inactivation of cytochrome P-450 by the drug methoxsalen. Journal of Pharmacology and Experimental Therapeutics 1986; 236: 237–247
   PubMed Web of Science ®Google Scholar
• Gasser R., Hauri H. P., Meyer U. A. The turnover of cytochrome P-450b. FEBS Letters 1982; 147: 239–242
   PubMed Web of Science ®Google Scholar
• Gerber N., Lynn R., Holcomb R., Weller W. L., Bush M. T. The metabolism of hexobarbital in mice and methodology for isolation and quantitation of its metabolites in vivo and in vitro. Journal of Pharmacology and Experimental Therapeutics 1971; 177: 234–245
   PubMed Web of Science ®Google Scholar
• Gorin I., Lessana-Leibowitch M., Fortier P., Leibowitch J., Escande J. P. Successful treatment of the pruritus of human immunodeficiency virus infection and acquired immunodeficiency syndrome with psoralens plus ultraviolet A therapy. Journal of the American Academy of Dermatology 1989; 20: 511–513
   PubMedGoogle Scholar
• Goujon F. M., Nebert D. W., Gielen J. E. Genetic expression of aryl hydrocarbon hydroxylase induction. IV. Interaction of various compounds with different forms of cytochrome P-450 and the effect on benzo[a]pyrene metabolism in vitro. Molecular Pharmacology 1972; 8: 667–680
   PubMed Web of Science ®Google Scholar
• Hilliard J. B., Mays D. C., Pacula C. M., Gerber N. The time course of in vivo covalent binding of a reactive metabolite of 8-methoxypsoralen with mouse hepatic microsomal protein. Federation Proceedings 1987; 46: 863
   Google Scholar
• Holcomb R. R., Gerber N., Bush M. T. The metabolic fate of hexobarbital in the rat. Journal of Pharmacology and Experimental Therapeutics 1974; 188: 15–26
   PubMedGoogle Scholar
• Labbe G., Descatoire V., Beaune P., Letteron P., Larrey D., Pessayre D. Suicide inactivation of cytochrome P-450 by methoxsalen. Evidence for the covalent binding of a reactive intermediate to the protein moiety. Journal of Pharmacology and Experimental Therapeutics 1989; 250: 1034–1042
   PubMed Web of Science ®Google Scholar
• Mandula B. B., Pathak M. A. Metabolic reactions in vitro of psoralens with liver and epidermis. Biochemical Pharmacology 1979; 28: 127–132
   PubMedGoogle Scholar
• Mays D. C., Rogers S. L., Guiler R. C., Sharp D. E., Hecht S. G., Staubus A. E., Gerber N. Disposition of 8-methoxypsoralen in the rat: methodology for measurement, dose-dependent pharmacokinetics, tissue distribution and identification of metabolites. Journal of Pharmacology and Experimental Therapeutics 1986; 236: 364–373
   PubMedGoogle Scholar
• Mays D. C., Camisa C., Cheney P., Pacula C. M., Nawoot S., Gerber N. Methoxsalen is a potent inhibitor of the metabolism of caffeine in humans. Clinical Pharmacology and Therapeutics 1987a; 42: 621–626
   PubMedGoogle Scholar
• Mays D. C., Hecht S. G., Unger S. E., Pacula C. M., Climie J. M., Sharp D. E., Gerber N. Disposition of 8-methoxypsoralen in the rat: induction of metabolism in vivo and in vitro and identification of urinary metabolites by thermospray mass spectrometry. Drug Metabolism and Disposition 1987b; 15: 318–328
   PubMed Web of Science ®Google Scholar
• Mays D. C., Nawoot S., Hilliard J. B., Pacula C. M., Gerber N. Inhibition and induction of drug biotransformation in vivo by 8-methoxypsoralen: studies of caffeine, phenytoin and hexobarbital metabolism in the rat. Journal of Pharmacology and Experimental Therapeutics 1987c; 243: 227–233
   PubMedGoogle Scholar
• Mays D. C., Hilliard J. B., Wong D. D., Gerber N. Activation of 8-methoxypsoralen by cytochrome P-450. Enzyme kinetics of covalent binding and influence of inhibitors and inducers of drug metabolism. Biochemical Pharmacology 1989; 38: 1647–1655
   PubMedGoogle Scholar
• Mays D. C., Hilliard J. B., Wong D. D., Chambers M. A., Park S. S., Gelboin H. V., Gerber N. Bioactivation of 8-methoxypsoralen and irreversible inactivation of cytochrome P-450 in mouse liver microsomes: modification by monoclonal antibodies, inhibition of drug metabolism and distribution of covalent adducts. Journal of Pharmacology and Experimental Therapeutics 1990; 254: 720–731
   PubMed Web of Science ®Google Scholar
• Nebert D. W., Nelson D. R., Adesnick M., Coon M. J., Estabrook R. W., Gonzalez F. J., Guengerich F. P., Gunsulas I. C., Johnson E. F., Kemper B., Levin W., Phillips I. R., Sato R., Waterman M. R. The P-450 superfamily: updated listing all of genes and recommended nomenclature for the chromosomal loci. DNA 1990; 8: 1–13
   Google Scholar
• Negishi M., Nebert D. W. Structural gene products of the Ah locus. Genetic and immunochemical evidence for two forms of mouse liver cytochrome P-450 induced by 3-methylcholanthrene. Journal of Biological Chemistry 1979; 254: 11015–11023
   PubMed Web of Science ®Google Scholar
• Sharp D. E., Mays D. C., Rogers S. L., Guiler R. C., Hecht S., Gerber N. In vitro metabolism of 8-methoxypsoralen. Proceedings of the Western Pharmacology Society 1984; 27: 255–258
   PubMedGoogle Scholar
• Tanew A., Ortel B., Rappersberger K., Honigsmann H. 5-Methoxypsoralen (Bergapten) for photochemotherapy. Bioavailability, phototoxicity, and clinical efficacy in psoriasis of a new drug preparation. Journal of the American Academy of Dermatology 1988; 18: 333–338
   PubMedGoogle Scholar
• Tsambacs D., Vizethum W., Goerz G. Effect of oral 8-methoxypsoralen on rat liver microsomal cytochrome P-450. Archives of Dermatological Research 1978; 263: 339–342
   PubMedGoogle Scholar
• Watkins P. B., Bond J. S., Guzelian P. S. Degradation of the hepatic cytochromes P-450. Mammalian Cytochromes P-450, P. F. Guengerich. CRC Press, Boca Raton, FL 1987; Vol. II: 173–192
   Google Scholar